
Shock as doctors discover staggering rise in type of cancer that can leave patients unable to control their bowels
Red flags include blood in bowel movements, pain, itching, small lumps around the anus and persistent, uncontrollable diarrhoea.
These issues can also be caused by other, more common conditions like haemorrhoids or anal fissures—but persistent or unusual symptoms should always be checked by a medical professional, add experts.
The warning comes after researchers analysed data from the US National Cancer Institute between 2017 and 2021, and found something surprising.
Overall, cases increased by three per cent in women and 1.6 per cent in men over the study period.
But white women aged 65 and over saw the most dramatic rise, with an annual increase of four per cent.
If these trends continue, scientists warn that anal cancer cases among women over 65 could double in less than 17 years.
The findings challenge long-held assumptions about who is most at risk, experts tracking the phenomenon say.
Screening guidelines have typically focused on people with HIV, men who have sex with men, organ transplant recipients and women with a history of vulvar cancer.
'Rates of anal cancer are rising fastest among white and Hispanic women over 65—groups not traditionally considered high risk,' said lead author Dr Ashley Robinson, a second-year internal medicine resident at Advocate Lutheran General Hospital.
Human papillomavirus, known as HPV, causes 90 per cent of anal cancers. In the UK, approximately 1,600 people are diagnosed each year.
While still considered rare, it makes up approximately one per cent of all gastrointestinal cancers.
Although the reason for the increase is still unclear, the experts suggested it is likely because the HPV vaccination was not recommended to older women when they were younger, despite being widely available now and offered in schools.
In the UK, the HPV jab was offered to all girls aged 12 to 13 in school year eight since September 2008, while eligibility was only expanded to boys in year eight from September 2019.
The jab significantly reduces your chances of catching HPV, which is spread through skin to skin contact, usually during sex.
The virus is normally harmless, but for reasons not fully understand can also trigger cancers, which alongside anal cancer also including those in the throat, penis, vagina and cervix.
'It's crucial that we promote HPV vaccination as a key tool for preventing anal cancer, while also keeping health care providers informed as screening guidelines evolve,' Dr Robinson said.
'These findings highlight specific patient groups who may benefit from targeted screening for anal HPV and anal cancer.'
Currently, older women are not screened for anal cancer and the findings of the study concluded that this could be beneficial.
It comes as the number of under-50s with bowel cancer in England is growing at one of the fastest rates in the world, a major study warns.
While cases of early onset bowel cancer, defined as those aged 25 to 49, is increasing globally, England's rate of the disease is growing by an average of 3.6 per cent each year – one of the fastest rises.
Experts believe poor diet, more ultra-processed foods, obesity and a lack of exercise could be responsible for the alarming trend.
The study found bowel cancer rates in young people rose in 27 out of the 50 countries studied in the decade to 2017.
Researchers from the American Cancer Society, who led the study, said the rise in early onset cancers is no longer limited to high-income Western countries but is now a 'global phenomenon'.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


The Independent
25 minutes ago
- The Independent
World-first gonorrhoea vaccine rolled out across UK amid record levels of infection
England has launched a world-first gonorrhoea vaccination programme, aimed at curbing soaring infection rates and tackling the growing threat of antibiotic-resistant strains. The initiative comes after cases of the sexually transmitted infection (STI) in England reached a record 85,000 in 2023, the highest since records began in 1918. Available free of charge from Monday at sexual health clinics, the jab is being offered to those at highest risk. This includes gay and bisexual men with a recent history of multiple sexual partners or a bacterial STI. The vaccine, an existing jab known as 4CMenB, is currently used to protect against meningococcal B disease, which can cause meningitis and sepsis. It is used in the routine childhood programme and given to babies at eight weeks, 16 weeks and one year. Officials anticipate the programme will save the NHS £7.9 million over the next decade. The programme could prevent up to 100,000 cases of gonorrhoea, according to doctors. The STI disproportionately impacts specific communities, such as those in deprived areas, people of black Caribbean ethnicity, and gay, bisexual and other men who have sex with men, according to the Joint Committee on Vaccination and Immunisation (JCVI). Patients getting the gonorrhoea vaccine will also be offered jabs for mpox, human papillomavirus (HPV), and hepatitis A and B at their appointment. 'Rolling out this world-leading gonorrhoea vaccination programme in sexual health clinics in England represents a major breakthrough in preventing an infection that has reached record levels,' Ashley Dalton, the minister for public health and prevention, said. 'This government's world-first vaccination programme will help turn the tide on infections, as well as tackling head-on the growing threat of antibiotic resistance. 'I strongly encourage anyone who is eligible to come forward for vaccination, to protect not only yourselves but also your sexual partners.'


Daily Mirror
a day ago
- Daily Mirror
New NHS vaccine available from today for 'antibiotic resistant' super strain
Cases in England topped 85,000 the highest since records began in 1918 A vaccine for gonorrhoea is now available at sexual health clinics in England as part of a world-first scheme. The vaccination programme is expected to save the NHS £7.9 million over the next decade and combat increasing levels of antibiotic-resistant strains of the disease. The move aims to tackle rising levels of the sexually transmitted infection (STI) after cases in England topped 85,000 in 2023, the highest since records began in 1918. The free jab will be on offer from Monday to patients at the highest risk of the sexually transmitted infection, including gay and bisexual men with a recent history of multiple sexual partners or a bacterial STI. The vaccine is an existing jab, known as 4CMenB, that is currently used to protect people against the meningococcal B disease, a serious bacterial infection that can cause meningitis and sepsis. It is used in the routine childhood programme and given to babies at eight weeks, 16 weeks and one year. The programme is targeted to those most at risk and could prevent up to 100,000 cases. Gonorrhoea disproportionately impacts specific communities, such as those in deprived areas, people of black Caribbean ethnicity, and gay, bisexual and other men who have sex with men, according to the Joint Committee on Vaccination and Immunisation (JCVI). Patients getting the gonorrhoea vaccine will also be offered jabs for mpox, human papillomavirus (HPV), and hepatitis A and B at their appointment. Ashley Dalton, the minister for public health and prevention, said: 'Rolling out this world-leading gonorrhoea vaccination programme in sexual health clinics in England represents a major breakthrough in preventing an infection that has reached record levels. 'This government's world-first vaccination programme will help turn the tide on infections, as well as tackling head-on the growing threat of antibiotic resistance. 'I strongly encourage anyone who is eligible to come forward for vaccination, to protect not only yourselves but also your sexual partners.' Consultant Epidemiologist at the UK Health Security Agency, Dr Sema Mandal said: "This roll out is hugely welcome as we're currently seeing very concerning numbers of gonorrhoea, including even more worryingly antibiotic resistant gonorrhoea. The vaccine will give much needed protection to those that need it most - making the UK a world leader in the fight against gonorrhoea. "And it's excellent to see that at the same time other important vaccines will continue to be offered in sexual health services to those eligible, protecting against mpox, hepatitis A and B, and HPV. Sexually transmitted infections aren't just an inconvenience – they can have a major impact on your health and your sexual partners, so if offered I strongly urge you to get these jabs, you'll be protecting yourself as well as others. Don't put it off and regret it later." What are the symptoms of gonorrhoea? According to the NHS, typical symptoms of gonorrhoea include a thick green or yellow discharge from the vagina or penis, and pain when urinating. In women, it can present as bleeding between periods. However, around one in 10 infected men and almost half of infected women do not experience any symptoms - meaning it's important to get tested if you've had unprotected sex. You can visit your local sexual health clinic to have a test, where a professional will perform a quick, painless test with a swab.


ITV News
a day ago
- ITV News
'World-first' gonorrhoea vaccine now offered at sexual health clinics in England
A vaccine for gonorrhoea is now available at sexual health clinics in England as part of a world-first scheme. The vaccination programme is expected to save the NHS £7.9 million over the next decade and combat increasing levels of antibiotic-resistant strains of the disease. The move aims to tackle rising levels of the sexually transmitted infection (STI) after cases in England topped 85,000 in 2023, the highest since records began in 1918. The free jab will be on offer from Monday to patients at the highest risk of the STI, including gay and bisexual men with a recent history of multiple sexual partners or a bacterial STI. The vaccine is an existing jab, known as 4CMenB, that is currently used to protect people against the meningococcal B disease, a serious bacterial infection that can cause meningitis and sepsis. It is used in the routine childhood programme and given to babies at eight weeks, 16 weeks and one year. The programme is targeted at those most at risk and could prevent up to 100,000 cases. Gonorrhoea disproportionately impacts specific communities, such as those in deprived areas, people of black Caribbean ethnicity, and gay, bisexual and other men who have sex with men, according to the Joint Committee on Vaccination and Immunisation (JCVI). Patients getting the gonorrhoea vaccine will also be offered jabs for mpox, human papillomavirus (HPV), and hepatitis A and B at their appointment. Ashley Dalton, the minister for public health and prevention, said: 'Rolling out this world-leading gonorrhoea vaccination programme in sexual health clinics in England represents a major breakthrough in preventing an infection that has reached record levels. 'This government's world-first vaccination programme will help turn the tide on infections, as well as tackling head-on the growing threat of antibiotic resistance. 'I strongly encourage anyone who is eligible to come forward for vaccination, to protect not only yourselves but also your sexual partners.'